#USA #Phoenix #Healthcare Solutions #Aqueous Health #Principle Diagnostics

Aqueous Health's Strategic Move in the Healthcare Industry

Aqueous Health has taken a bold step into the diagnostics sector by announcing a majority investment in Principle Diagnostics, adding a new layer to its healthcare services portfolio. This collaboration signals a merging of expertise aimed at reshaping how diagnostic services are delivered in the post-pandemic world. Founded in 2015, Principle Diagnostics, based in Bethlehem, PA, has established itself as a leader in toxicology and genetic testing services, catering to a diverse demographic that includes patients, healthcare providers, and other laboratories.

Dan Eckert, who has been appointed as the Chairman and CEO of Aqueous Health, brings over 40 years of industry experience, particularly in healthcare leadership roles. His vision is clear: to leverage the combined strengths of Aqueous Health and Principle Diagnostics to create a frontrunner in the diagnostics field. "Joining forces with Dr. Allan Zyller and his exceptional team at Principle Diagnostics allows us to offer cutting-edge predictive diagnostic testing to a wider audience," Eckert stated.

Fulfilling a Greater Need

The COVID-19 pandemic underscored the urgent need for accessible and rapid diagnostic testing, which Aqueous Health aims to satisfy. Eckert elaborates on the challenges many face in getting tested, such as accessibility, fear of testing procedures, and time constraints. Understanding these hurdles is central to Aqueous Health's strategic plan.

To address these issues, Aqueous Health plans to provide innovative solutions that meet consumers wherever they are. This includes the rollout of rapid point-of-care tests, over-the-counter options, and home sampling kits to be lab-tested, encapsulated under the philosophy of “Diagnostics Anywhere.” By streamlining the testing process, Aqueous Health aims to enhance the management of health and wellness among individuals.

A Commitment to Quality

Gina Mattes, the current CEO of Principle Labs, will continue to lead the operations at Principle Diagnostics. She expresses great optimism about the future of their services. "For more than ten years, our team has ensured the highest quality of diagnostic testing. With Aqueous's backing, we are positioned to enhance our offerings significantly," she remarked.

Dr. Zyller, who will remain involved as a board member and investor, highlights the importance of this move for the stakeholders involved. "This partnership marks a pivotal moment for Principle Diagnostics, setting the stage for growth and innovation that benefits everyone involved."

Future Growth Plans

Based out of Phoenix, AZ, Aqueous Health plans to maintain the existing infrastructure of Principle Diagnostics in Bethlehem, PA, as a wholly-owned subsidiary. The company also has plans to invest further in diagnostic health and wellness markets, with additional operations slated for establishment in Phoenix to support sustainable growth.

This investment is bolstered by a partnership with Berkery Noyes, where Lou Grecco serves as the exclusive financial advisor for Principle Diagnostics. Legal advisory for Aqueous Health is provided by Polsinelli, showcasing the thorough planning behind this strategic investment.

By aligning with Principle Diagnostics, Aqueous Health is not just entering the diagnostics market but is poised to revolutionize it. The dedicated and experienced team led by Eckert and Mattes is set to change how people access healthcare solutions, stressing an easier, more proactive approach to personal health management.

As the healthcare landscape evolves, entities like Aqueous Health and Principle Diagnostics exemplify the innovation and integration necessary to meet the demands of modern health management. Their joint venture represents a promising future for accessible, efficient, and effective diagnostic solutions.